RhumbLine Advisers
CABA icon

RhumbLine Advisers’s Cabaletta Bio CABA Stock Holding History

RhumbLine Advisers’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-61,388
Closed -$85K – 4157
2025
Q1 		$85K Sell
61,388
-2,033
-3% -$4.33K ﹤0.01% 3445
2024
Q4 		$144K Buy
63,421
+2,851
+5% +$10K ﹤0.01% 3355
2024
Q3 		$286K Sell
60,570
-1,310
-2% -$7.58K ﹤0.01% 3049
2024
Q2 		$463K Buy
61,880
+16,274
+36% +$199K ﹤0.01% 2740
2024
Q1 		$778K Buy
45,606
+1,459
+3% +$31.3K ﹤0.01% 2396
2023
Q4 		$1M Buy
44,147
+1,545
+4% +$26K ﹤0.01% 2251
2023
Q3 		$648K Buy
42,602
+13,622
+47% +$186K ﹤0.01% 2452
2023
Q2 		$374K Buy
+28,980
New +$315K ﹤0.01% 2879
2021
Q2 		– Sell
-14,694
Closed -$163K – 3003
2021
Q1 		$163K Sell
14,694
-760
-5% -$9.28K ﹤0.01% 2872
2020
Q4 		$193K Buy
15,454
+2,709
+21% +$35.1K ﹤0.01% 2849
2020
Q3 		$138K Sell
12,745
-2,284
-15% -$26.3K ﹤0.01% 2798
2020
Q2 		$167K Buy
+15,029
New +$115K ﹤0.01% 2833

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

RhumbLine Advisers's CABA Position: Q2 2025 in Review

RhumbLine Advisers sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 61,388 shares — an estimated $85K sold.

RhumbLine Advisers first reported a position in CABA in Q2 2020 and held it in 12 quarters. The position peaked at $1M in Q4 2023. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

  • RhumbLine Advisers reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 61,388 Cabaletta Bio shares in Q2 2025, an estimated $85K.
  • RhumbLine Advisers first reported a position in Cabaletta Bio in Q2 2020 and held it in 12 quarters.
  • RhumbLine Advisers's Cabaletta Bio position peaked at $1M in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.